Cargando…
Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease”
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Turkish Society of Cardiology
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893712/ https://www.ncbi.nlm.nih.gov/pubmed/36680451 http://dx.doi.org/10.14744/AnatolJCardiol.2022.2335 |
| _version_ | 1784881585306206208 |
|---|---|
| author | Güzel, Tuncay Aktan, Adem Kılıç, Raif Arslan, Bayram Demir, Muhammed Özbek, Mehmet Ertaş, Faruk |
| author_facet | Güzel, Tuncay Aktan, Adem Kılıç, Raif Arslan, Bayram Demir, Muhammed Özbek, Mehmet Ertaş, Faruk |
| author_sort | Güzel, Tuncay |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9893712 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Turkish Society of Cardiology |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98937122023-02-14 Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease” Güzel, Tuncay Aktan, Adem Kılıç, Raif Arslan, Bayram Demir, Muhammed Özbek, Mehmet Ertaş, Faruk Anatol J Cardiol Letter to the Editor Turkish Society of Cardiology 2023-01-01 /pmc/articles/PMC9893712/ /pubmed/36680451 http://dx.doi.org/10.14744/AnatolJCardiol.2022.2335 Text en 2023 authors https://creativecommons.org/licenses/by-nc/4.0/ Content of this journal is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. (https://creativecommons.org/licenses/by-nc/4.0/) |
| spellingShingle | Letter to the Editor Güzel, Tuncay Aktan, Adem Kılıç, Raif Arslan, Bayram Demir, Muhammed Özbek, Mehmet Ertaş, Faruk Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease” |
| title | Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease” |
| title_full | Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease” |
| title_fullStr | Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease” |
| title_full_unstemmed | Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease” |
| title_short | Reply to Letter to the Editor: “Anticoagulation in Real-Life Patients with Atrial Fibrillation: Impact of Renal Disease” |
| title_sort | reply to letter to the editor: “anticoagulation in real-life patients with atrial fibrillation: impact of renal disease” |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9893712/ https://www.ncbi.nlm.nih.gov/pubmed/36680451 http://dx.doi.org/10.14744/AnatolJCardiol.2022.2335 |
| work_keys_str_mv | AT guzeltuncay replytolettertotheeditoranticoagulationinreallifepatientswithatrialfibrillationimpactofrenaldisease AT aktanadem replytolettertotheeditoranticoagulationinreallifepatientswithatrialfibrillationimpactofrenaldisease AT kılıcraif replytolettertotheeditoranticoagulationinreallifepatientswithatrialfibrillationimpactofrenaldisease AT arslanbayram replytolettertotheeditoranticoagulationinreallifepatientswithatrialfibrillationimpactofrenaldisease AT demirmuhammed replytolettertotheeditoranticoagulationinreallifepatientswithatrialfibrillationimpactofrenaldisease AT ozbekmehmet replytolettertotheeditoranticoagulationinreallifepatientswithatrialfibrillationimpactofrenaldisease AT ertasfaruk replytolettertotheeditoranticoagulationinreallifepatientswithatrialfibrillationimpactofrenaldisease |